Komori
Treasury Shares4577Daito Pharmaceutical Co.,Ltd.Pharmaceuticals

Notice Regarding the Results of the Acquisition of Treasury Shares through an Off-Auction Purchase (ToSTNeT-3) and the Completion of the Acquisition of Treasury Shares

On 13 July 2026, the company acquired 484,000 treasury shares for ¥605 million through ToSTNeT-3 and completed the treasury share acquisition conducted pursuant to the resolution of the Board of Directors dated 10 July 2026.

Worth reading
71In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
605000000
¥
Wording
Definitive
How definitive the wording is.

Progress against acquisition limit

Acquisition completedOff-auction purchase (ToSTNeT-3)

Resolved 10 July 2026 / Acquisition period 13 July 2026

96.8%
Cumulative utilization rate
Limit
Number of Shares500,000 shares (maximum)
96.8%
Cumulative utilization rate
Limit
Amount¥625,000,000 (maximum)

今回の取得が、そのまま決議後の累計です。 株数・金額とも枠をほぼ使い切っています。

Number of Shares
Limit500,000 shares (maximum)
Cumulative total484,000 shares (as of 13 July 2026; appears to represent the cumulative acquisition under the resolution of the Board of Directors dated 10 July 2026, although it is not explicitly identified as cumulative)
Current484,000 shares
Amount
Limit¥625,000,000 (maximum)
Cumulative total¥605,000,000 (as of 13 July 2026; appears to represent the cumulative acquisition under the resolution of the Board of Directors dated 10 July 2026, although it is not explicitly identified as cumulative)
Current¥605,000,000
Percentage of total issued shares1.7%
Average acquisition price for this transaction (calculated)¥1,250 per shareCurrent acquisition price ÷ current number of shares acquired
Whether acquisition has been completed

Completed. The acquisition ended with the acquisition on 13 July 2026.

消化率と残りは、会社が示した累計・今回と上限から算出しています。進捗率=上限に対してどこまで使ったかの割合です。 ToSTNeT is a system for trading outside the exchange's regular trading hours.

Progress against acquisition limit
ItemDetails
Total number of shares acquired in this transaction484,000 shares
Total current acquisition price¥605,000,000
Acquisition date/acquisition period13 July 2026
Method of acquisitionOff-auction purchase (ToSTNeT-3)
Cumulative number of shares acquired484,000 shares (as of 13 July 2026; appears to represent the cumulative acquisition under the resolution of the Board of Directors dated 10 July 2026, although it is not explicitly identified as cumulative)
Cumulative acquisition cost¥605,000,000 (as of 13 July 2026; appears to represent the cumulative acquisition under the resolution of the Board of Directors dated 10 July 2026, although it is not explicitly identified as cumulative)
Resolution date10 July 2026
Maximum number of shares to be acquired500,000 shares (maximum)
Total acquisition price¥625,000,000 (maximum)
Acquisition period under the resolution13 July 2026
Percentage of total issued shares1.7%
Whether acquisition has been completedCompleted. The acquisition ended with the acquisition on 13 July 2026.
Items this document does not state (1)
Average Acquisition Price

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To strengthen shareholder returns and improve capital efficiency as part of the capital policy under the medium-term management plan.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Results of the Acquisition of Treasury Shares through an Off-Auction Purchase (ToSTNeT-3) and the Completion of the Acquisition of Treasury Shares | Daito Pharmaceutical Co.,Ltd. (4577) timely disclosure | Komori